AB
KRTX

Amalgamated Bank’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Amalgamated Bank’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6,986
Closed -$2.21M – 2981
2023
Q4 		$2.21M Sell
6,986
-913
-12% -$177K 0.02% 868
2023
Q3 		$1.34M Buy
7,899
+584
+8% +$110K 0.01% 1015
2023
Q2 		$1.59M Buy
7,315
+2,837
+63% +$608K 0.01% 967
2023
Q1 		$813K Sell
4,478
-484
-10% -$92.6K 0.01% 1193
2022
Q4 		$975K Buy
4,962
+93
+2% +$19.9K 0.01% 1168
2022
Q3 		$1.09M Buy
4,869
+714
+17% +$145K 0.01% 1074
2022
Q2 		$526K Buy
4,155
+521
+14% +$59.9K ﹤0.01% 1436
2022
Q1 		$461K Sell
3,634
-275
-7% -$31K ﹤0.01% 1583
2021
Q4 		$512K Sell
3,909
-40
-1% -$5.17K ﹤0.01% 1559
2021
Q3 		$483K Sell
3,949
-243
-6% -$28.1K ﹤0.01% 1597
2021
Q2 		$478K Buy
4,192
+1,947
+87% +$228K ﹤0.01% 1669
2021
Q1 		$270K Sell
2,245
-224
-9% -$25.4K 0.01% 1331
2020
Q4 		$251K Buy
+2,469
New +$229K 0.01% 1326
2020
Q3 		– Sell
-2,483
Closed -$277K – 1524
2020
Q2 		$277K Buy
+2,483
New +$216K 0.01% 1157

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Amalgamated Bank's KRTX Position: Q1 2024 in Review

Amalgamated Bank sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 6,986 shares — an estimated $2.21M sold.

Amalgamated Bank first reported a position in KRTX in Q2 2020 and held it in 14 quarters. The position peaked at $2.21M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Amalgamated Bank reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Amalgamated Bank sold 6,986 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.21M.
  • Amalgamated Bank first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2020 and held it in 14 quarters.
  • Amalgamated Bank's Karuna Therapeutics, Inc. Common Stock position peaked at $2.21M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Amalgamated Bank's 13F filing for Q1 2024, filed 23 Apr 2024.